Trial Profile
A trial to study the incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemo-immunotherapy with rituximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 12 May 2016 New trial record